These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6884739)

  • 1. [Therapeutic efficacy of enteral administration of aminokrovin and zylite in patients with liver cirrhosis].
    Sukhorukov VP; Shishkin BA; Prozorov IuG
    Gematol Transfuziol; 1983 Jun; 28(6):32-4. PubMed ID: 6884739
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enteric use of a 10% xylite solution based on aminokrovin in preparing peptic ulcer patients for stomach resection].
    Zhuravlev VA; Golovchenko IuA; Prozorov IuG; Sukhorukov VP; Rommer SI
    Probl Gematol Pereliv Krovi; 1977 Dec; 22(12):16-8. PubMed ID: 600936
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is intravenous albumin relevant in the treatment of patients with liver disease?].
    Henriksen JH
    Ugeskr Laeger; 2002 Feb; 164(9):1202-3. PubMed ID: 11899506
    [No Abstract]   [Full Text] [Related]  

  • 4. [Albumin in decompensated liver cirrhosis].
    Gøtzche PC
    Ugeskr Laeger; 2002 Feb; 164(9):1203-4. PubMed ID: 11899507
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of albumin infusion in decompensated liver cirrhosis].
    Schmidt LE; Ring-Larsen H
    Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of the therapeutic effectiveness of the blood substitute, rheogluman, in internal diseases].
    Voronina LN; Polushina TV; Miterev IuG; Zherebtsov LA; Solov'eva TI
    Sov Med; 1979 Aug; (8):11-5. PubMed ID: 515820
    [No Abstract]   [Full Text] [Related]  

  • 7. [Xylitol and possibilities of its clinical use].
    Suslev VS
    Klin Med (Mosk); 1973 Mar; 51(3):8-15. PubMed ID: 4205053
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of human albumin for the treatment of ascites in patients with liver cirrhosis: item of safety, facts, controversies and perspectives.
    Facciorusso A; Nacchiero MC; Rosania R; Laonigro G; Longo N; Panella C; Ierardi E
    Curr Drug Saf; 2011 Sep; 6(4):267-74. PubMed ID: 22129322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic effects of calcium-2,2'-disulfohexanoate in hepatic cirrhosis].
    Cangiano C; Angelico M; Rossi Fanelli F
    Clin Ter; 1978 Aug; 86(4):337-53. PubMed ID: 737963
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of cirrhotic complications with human serum albumin].
    Henriksen JH; Ring-Larsen H
    Ugeskr Laeger; 2005 Jan; 167(4):414. PubMed ID: 15719571
    [No Abstract]   [Full Text] [Related]  

  • 11. RENAL EFFECTS OF ACUTE EXPANSION OF PLASMA VOLUME IN CIRRHOSIS.
    VLAHCEVIC ZR; ADHAM NF; JICK H; MOORE EW; CHALMERS TC
    N Engl J Med; 1965 Feb; 272():387-90. PubMed ID: 14242512
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasoactive factors in the mechanism of renal sodium handling in cirrhotics: the effect of acute plasma expansion.
    Laffi G; La Villa G; Pinzani ; Mannelli M; Buzzelli G; Paladini S; Pampana A; Smorlesi C; Pedretti G; Gentilini P
    Pharmacol Res Commun; 1984 Jun; 16(6):613-35. PubMed ID: 6431453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental observations on the changes in renal function and acid-base equilibrium during chronic liver diseases].
    Agnoli GC; Bernardi P; Cariani A; Montini T
    Boll Soc Ital Biol Sper; 1969 Dec; 45(23):1511-5. PubMed ID: 5401718
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diuretic therapy of Morgagni-Laennec's hepatic cirrhosis].
    De Martiis M; Fontana M; Venditti A
    Clin Ter; 1972 Jun; 61(6):509-43. PubMed ID: 4669750
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolic effects of parenteral administration of glucose, fructose, sorbitol and xylitol in cirrhotic and healthy subjects].
    Brodanová M; Brodan V; Filip J; Kuhn E
    Cas Lek Cesk; 1976 Apr; 115(13):387-93. PubMed ID: 1260815
    [No Abstract]   [Full Text] [Related]  

  • 16. Pilot study: Gelafundin (polygeline) 4% plus antibiotics in the treatment of high-risk cirrhotic patients with spontaneous bacterial peritonitis.
    Cartier M; Terg R; Lucero R; Muñoz A; Romero G; Levi D; Miguez C; Abecasis R
    Aliment Pharmacol Ther; 2010 Jul; 32(1):43-8. PubMed ID: 20345510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of xylitol in long-term parenteral nutrition in dogs.
    Meng HC; Anderson GE
    Z Ernahrungswiss Suppl; 1973; 15():54-68. PubMed ID: 4201154
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal failure in cirrhosis--role of plasma volume.
    Papper S; Vaamonde CA
    Ann Intern Med; 1968 Apr; 68(4):958-9. PubMed ID: 5642977
    [No Abstract]   [Full Text] [Related]  

  • 19. [ON THE SURGICAL TREATMENT OF PATIENTS WITH PORTAL HYPERTENSION COMPLICATED BY ASCITES].
    ZHURAVLEV VA
    Vestn Khir Im I I Grek; 1964 Jan; 92():29-33. PubMed ID: 14162726
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative evaluation of different methods of administration of aminokrovin in treatment of hypotrophy in children].
    SHUMKOVA RD
    Pediatriia; 1962 Apr; 41():12-4. PubMed ID: 13912407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.